The Pro-Daptive™ SensorCell™ Flotation Surface is a powered therapeutic mattress that provides a new generation of therapeutic flotation. LeviSense combines SensorCell technology with surface visualization and control to achieve what traditional surfaces can’t: programmable immersion and outstanding envelopment for unmatched pressure redistribution, with meaningful labor and cost savings across the continuum of care.
CataloguesPrevention has not become meaningfully easier, and treatment still requires arduous, around-the-clock care. The technology beneath the patient has changed very little over the past decades: conventional surfaces redistribute pressure across large sections of the body, but cannot respond with precision to small bony prominences, wounds, or changing clinical needs.
Caregivers are left to compensate — repeatedly repositioning patients, floating heels, off-loading wounds and adapting the surface by hand. The burden falls hardest on the 400,000 Americans living with spinal cord injury, where recurrence runs as high as 80%, and the 5.5 million who are bed-bound.
Developed in collaboration with wound care specialists and validated through laboratory testing, Pro-Daptive™ is built to promote and accelerate healing of advanced pressure injuries, including Stage III, Stage IV, unstageable, post-flap and post-graft, in hospitals, acute care, long-term care and home care settings.
For those at high risk of developing pressure injuries, such as patients who are bed-bound or have mobility limitations due to:
Superior immersion and envelopment, in a simplified, accessible platform.
More than 200 small-diameter SensorCell™s. Each SensorCell™ moves independently—rising or yielding—in response to the patient’s weight and contours. Each cell adjusts to provide support or relief where it is needed—even around small bony prominences—creating exceptional immersion and envelopment while minimizing areas of concentrated pressure.
A special function – Heel Float – allows the caregiver to protect the most vulnerable areas by creating a void and completely off-loading the heels.


Firm enough to facilitate transfers in and out of the bed, greatly reduce the effort required to reposition a patient, and firm enough for CPR.
The patient can find a mattress firmness suited to their own preference for rest and healing.
Depressed cells will not push back up, creating a cavity to off-load a wound, a void to cradle a painful area, or floating the feet and heels. No more boots.

Set to 70 mmHg: a firm surface for ingress, egress, transfers, linen changes and CPR. Cuts the effort of repositioning by more than 30%; afterwards the SensorCell™s cradle the patient in place without wedges or pillows.

Preset to 26 mmHg. The pressure can be raised or lowered by 2 mmHg increments for clinical or comfort reasons.

Separate memorized adjustments for four independent zones.

Drop a group of cells to ≤ 5 mmHg and they stop pushing back: the heels float free, or a cavity opens under an existing wound, while the rest of the surface holds its therapeutic setting.
T0
T1
T2
T3
T4
T5
Five programmed phases provide continuous, hands-free off-loading: a gentle tilt followed by four Support Flow™ phases that shift areas of loading and relief without disturbing restful sleep. Runs 50-minute cycles of gentle load repositioning, repeating for up to 10 hours — overnight support for caregivers at home.
Navigate to all five modes from the touchscreen. One touch initiates an immediate response and a rapid transition between modes.
Two alternatives for quick access from the monitor.
Group II alternating pressure mattresses (APM) offer limited immersion and envelopment, which reduces their effectiveness for complex wounds. Group III air fluidized therapy (AFT) beds provide immersion and envelopment but lack targeted pressure redistribution, precise off-loading and customizable control.
Both are typically preset by the manufacturer, largely by patient weight, yet weight alone does not predict an individual’s pressure redistribution needs or skin tolerance. Pro-Daptive™ lets clinicians customize therapy for each patient.
| FEATURE | PRO-DAPTIVE™ | ALTERNATING PRESSURE LOW AIR LOSS | AIR FLUIDIZED THERAPY |
|---|---|---|---|
| Stages III, IV, Unstageable | ✓ | ◐ | ✓ |
| Immersion | ✓ | ◐ | ✓ |
| Envelopment | ✓ | ◐ | ✓ |
| Flotation | ✓ | ◐ | ✓ |
| Adaptive | ✓ | ✕ | ✕ |
| Pressure Redistribution | ✓ | ✓ | ✓ |
| Complete Off-Loading | ✓ | ✕ | ✕ |
| Custom Cavity Creation | ✓ | ✕ | ✕ |
| Customizable Therapy | ✓ | ✕ | ✕ |
| Patient Comfort | ✓ | ✓ | ◐ |
| Adjustable Microclimate Control | ✓ | ✕ | ✕ |
| Ease of Transfer | ✓ | ✓ | ✕ |
| Ease of Repositioning | ✓ | ✓ | ◐ |
| Bariatric Sizes 42″ & 48″ (107 & 122 cm) | ✓ | ✓ | ✕ |
| Home Care | ✓ | ✓ | ◐ |
AFT, the Group III “sand bed”, was developed in 1968 and has long been considered the most effective surface for Stage III–IV and unstageable wounds, post-flap, post-graft and burn patients. It is also expensive to acquire and maintain, labor intensive, and associated with surface instability, patient dehydration, difficult repositioning and transfer, cleaning challenges and limited home care availability.
Pro-Daptive™ supports patients across the continuum of care, from the ICU and long-term care to the home. Rather than stepping down to a standard Group II alternating pressure surface at discharge, patients can continue the same prescribed therapy on the same platform.
The cost of an unsuccessful transition is measured in longer stays, caregiver burden, wound-care expenses and readmissions. Protecting fragile tissue through that transition helps preserve healing and reduce costly setbacks.
A versatile surface designed to meet the needs of acute care, long-term care and home care settings and frames, including bariatric.
Hundreds of independent cells, each 2.5 inches (6.4 cm) in diameter, form the pelvis, legs and foot section of the surface. Each cell reacts independently to control pressure, so the surface conforms to body contours and provides envelopment rather than holding one uniform pressure. The torso section uses high volume air cells with adjustable support.
It is intended for the treatment and prevention of decubitus ulcers. On the treatment side, that includes high acuity patients with severe wounds such as Stage III, Stage IV and unstageable pressure injuries. On the prevention side, it is for those at high risk, such as patients who are bed-bound or have mobility limitations from spinal cord injury, MS, ALS, CP, stroke, amputation, or rehabilitation from disease or injury.
Five: Mobility, Immersion, Custom Immersion, Heel Flotation/Cavity Creation, and Dynamic Off-Loading™. One touch initiates an immediate response and a rapid transition between modes.
For more information about the product or becoming a distributor, contact us.
Select Specifications
Air Pump
Dimensions
22 x 27 x 42 cm
Supply Voltage/Frequency
Flow Rate (Liter/Minute)
1000
Control Panel Type
Touch Screen
Mode
Mobility, Immersion, Custom Immersion, Heel Flotation/Cavity Creation, and Dynamic Off-Loading
Independently Adjustable Zones
14
Repositioning Countdown Timer
Yes
IEC 60601-1-8 Alarm System
Yes
Power Cord Type
Detachable
Air Mattress
Height
Dimensions
Number of Cells
Pelvis, Legs and Foot Section
SensorCell™
Torso Section
Air Cells
Top Cover Material
Four-Way Stretch
Enhanced Isolated Air Flow™
Yes
CPR
CPR Mode and Q-CPR Valve
Maximum Patient Weight (kg)
180 to 250